Journal
CURRENT OPINION IN VIROLOGY
Volume 3, Issue 5, Pages 537-541Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.coviro.2013.05.020
Keywords
-
Categories
Ask authors/readers for more resources
A key to biodefense strategies is an assessment of current therapies available as well as the expedited development of new antiviral therapeutic options. Viruses make up the majority of the National Institute of Allergy and Infectious Diseases (NIAID) Category A Priority Pathogens, agents that are considered to pose the greatest risk to public health and national security, and yet there are currently no approved treatments for most of these viral biodefense threats. A review of the Category A viral biothreat agents and strategies for the development of new therapeutics are presented here.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available